March 17, 2016 by Chain Drug Review
Alex Gourlay, Larry Renfro, OptumRx, PBM, pharmacy benefit manager, pharmacy care, prescription drug services, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. and EDEN PRAIRIE, Minn. — Walgreens and pharmacy benefit manager OptumRx are collaborating on an an integrated pharmacy care solution that blends attributes of in-store and mail-order prescription drug services. The companies said Thursday that OptumRx members enrolled in the program will get the option to fill 90-day prescriptions at home delivery co-payment levels at
February 8, 2016 by Scot Meyer
Alex Gourlay, J.C. Penney, Lee Culpepper, Myron Ullman, National Retail Federation, NRF, retail industry, Retail's Big Show, Walgreens, Walmart
2016, Issue 02-08-2016, Issues, News
NEW YORK — Walgreen Co. was among the firms honored by the National Retail Federation at the trade association’s convention here last month. Walgreens was named Retail Innovator of the Year at the NRF’s convention and expo, dubbed Retail’s Big Show. According to NRF, the award is given annually to “a company that is well
January 19, 2016 by Chain Drug Review
Alex Gourlay, Lee Culpepper, Matthew Shay, Myron Ullman III, National Retail Federation, NRF Retail's Big Show, Walgreens, Walmart
Leading Headlines, Retail News
NEW YORK — Walgreens was presented with the Retail Innovator of the Year award by the National Retail Federation at the NRF Retail’s Big Show in New York City. Alex Gourlay, president of Walgreens, accepted the award on behalf of the drug chain from Claudio Del Vecchio, chairman and chief executive officer of Brooks Brothers.
January 4, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, CVS Health, J. Michael Pearson, Larry Merlo, Valeant Pharmaceuticals International, Walgreens
2016, Issue 01-04-2016, Issues, News
DEERFIELD, Ill. — Walgreens and Valeant Pharmaceuticals International Inc. have inked a distribution deal that will cut prices of Valeant prescription products at Walgreens by 10%, and may be extended to independent retail pharmacies. The discount will apply to wholesale list prices and will be phased in over the next six to nine months. The
December 15, 2015 by Chain Drug Review
Alex Gourlay, branded prescription drugs, J. Michael Pearson, Valeant Pharmaceuticals International, video, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
LAVAL, Quebec, and DEERFIELD, Ill. — Valeant Pharmaceuticals International Inc. and Walgreens have entered agreements in which the drug maker will directly distribute branded prescription drugs in a range of therapeutical areas to the pharmacy chain at reduced pricing. Valeant said Monday that, under the fulfillment agreement, it will cut the wholesale list prices of
November 9, 2015 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, chain drug retailing, CVS/pharmacy, Drug Channels Institute, George Fairweather, John Standley, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2015, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium
November 9, 2015 by Geoff Walden and Chain Drug Review
Alex Gourlay, Alliance Boots, AmerisourceBergen, Linda Filler, Richard Ashworth, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Business, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The acquisition of Rite Aid Corp. culminates sweeping change at Walgreens in the space of a little over three years. In linking its fortunes, starting in June 2012, to Alliance Boots GmbH and its dynamic leader, Stefano Pessina, the chain adopted a global outlook focusing simultaneously on scale and efficiency. Its merger
October 28, 2015 by Chain Drug Review
Alex Gourlay, George Fairweather, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
CDR Blog
The morning after announcing its $17.2 billion agreement to acquire Rite Aid, Walgreens Boots Alliance (WBA) didn’t have much to say about the deal. In a conference call on WBA’s fiscal 2015 results, company executives cited the synergies of scale and broader U.S. market coverage that the addition of Rite Aid promises, but details weren’t
October 12, 2015 by David Pinto and Chain Drug Review
Alex Gourlay, chain drug retailing, CVS Health, David Pinto, Helena Foulkes, John Standley, Ken Martindale, Larry Merlo, Ornella Barra, Rite Aid, Walgreens, Walgreens Boots Alliance
2015, Issue 10-12-2015, Issues, Opinion
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
September 2, 2015 by Chain Drug Review
#giveashot, Alex Gourlay, Get a Shot. Give a Shot, Kathy Calvin, life-saving vaccines, United Nations Foundation, Walgreens, Walgreens pharmacy
Leading Headlines, Retail News, Videos
DEERFIELD, Ill. — Walgreens and the United Nations Foundation have kicked off their annual “Get a Shot, Give a Shot” campaign, which aims to provide life-saving vaccines where they’re most needed to children worldwide. Walgreens said Wednesday that under the initiative, now in its third year, the company will help provide a life-saving vaccine for
July 29, 2015 by Chain Drug Review
Alex Gourlay, Craig Kielburger, Give H2OPE to Others, Me to We, Todd Tillemans, Unilever, Walgreens
Supplier News
ENGLEWOOD CLIFFS, N.J. — Unilever and Walgreens have partnered with Me to We to provide customers with a way to make a positive impact on the world through everyday purchases. Unilever said Wednesday that via the Give H2OPE to Others (#GiveH2OPE) initiative, Walgreens customers can make a life-changing difference for children and families in need.
July 13, 2015 by Chain Drug Review and Chain Drug Review
100000 Opportunities Initiative, Alex Gourlay, Brian Cornell, CVS Health, Doug McMillon, Larry Merlo, Target Corp., Walgreens, Walmart
Business, Featured Articles, Leading Headlines, Retail News
CHICAGO — CVS Health, Walgreens, Walmart and Target are among more than a dozen U.S.-based companies forming the 100,000 Opportunities Initiative, an employer-led coalition that aims to create pathways to jobs for America’s young people. The coalition has set a goal to engage at least 100,000 “Opportunity Youth” — 16- to 24-year-olds who face systemic
June 1, 2015 by Mark Baumgartner and Chain Drug Review
Alex Gourlay, Linn Jordan, Red Nose Day, Red Nose Fund, Walgreens, Walgreens Boots Alliance
2015, Issue 06-01-2015, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) says it exceeded its initial goal of raising $5 million in support of the Red Nose Day campaign to raise money for children and young people living in poverty. As of Red Nose Day, WBA had raised $7 million, according to Linn Jordan, director of marketing, strategy
June 1, 2015 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, Jeffrey Woldt, Walgreens, Walgreens Boots Alliance
2015, Issue 06-01-2015, Opinion
Most people in this country spent last Christmas Eve away from work, celebrating the holiday with family members and friends. Alex Gourlay, then Walgreens’ president of customer experience and daily living, devoted much of the day to visiting a dozen of the drug chain’s outlets in greater Chicago. His goal was to connect with store-level